HomeZNTL • NASDAQ
Zentalis Pharmaceuticals Inc
add
$1.95
5.98%
After Hours:(0.00%)0.00
$1.95
Closed: Mar 12, 4:01:32 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 51.43M | -17.99% |
Net income | -40.16M | 27.68% |
Net profit margin | — | — |
Earnings per share | -0.56 | 29.11% |
EBITDA | -51.11M | 18.05% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 391.25M | -24.27% |
Total assets | 450.66M | -23.06% |
Total liabilities | 96.33M | -7.21% |
Total equity | 354.33M | — |
Shares outstanding | 71.27M | — |
Price to book | 0.37 | — |
Return on assets | -27.29% | — |
Return on capital | -31.20% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -40.16M | 27.68% |
Cash from operations | -44.05M | -13.91% |
Cash from investing | 48.24M | 141.08% |
Cash from financing | 92.00K | -70.23% |
Net change in cash | 4.29M | 102.75% |
Free cash flow | -29.16M | -56.04% |
Previous close
$1.84
Day range
$1.83 - $1.98
Year range
$1.61 - $16.25
Market cap
138.97M USD
Avg Volume
1.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
124
